KIEL LAB INC has a total of 29 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are L A M PHARMACEUTICALS LLC, CYPROS PHARM CORP and NEW LIFE PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 8 | |
#3 | Canada | 5 | |
#4 | EPO (European Patent Office) | 5 | |
#5 | Australia | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Sugars | |
#3 | Therapeutic chemical compounds | |
#4 | Unspecified technologies | |
#5 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Kiel Jeffrey S | 29 |
#2 | Mani Narasimhan | 24 |
#3 | Thomas H Greg | 15 |
#4 | Thomas Greg H | 11 |
#5 | Todebush Richard Andrew | 2 |
#6 | Thomas H Gregory | 1 |
#7 | Harned George T Iii | 1 |
#8 | Ware Brady Neal | 1 |
#9 | Thomas Gregory H | 1 |
#10 | Ware Emily C | 1 |
Publication | Filing date | Title |
---|---|---|
US2009062191A1 | Composition for maintaining gastrointestinal homeostasis | |
US2008015260A1 | Pharmaceutical compositions having improved stability and methods for preparation and use | |
WO2005089721A1 | In process conversion method for preparing tannate tablet, capsule or other solid dosage forms | |
WO2005092096A1 | Single tank process for preparing tannate liquid and semi-solid dosage forms | |
EP1628656A2 | Gabapentin tannate in liquid and/or semi-solid dosage forms | |
WO2004093866A1 | Process for preparing phenolic acid salts of gabapentin | |
EP1622603A2 | Phenolic acid salts of gabapentin in solid dosage forms and methods of use | |
AU2003217703A1 | Diphenhydramine tannate solid dose compositions and methods of use | |
US2003077321A1 | Process for preparing tannate tablet, capsule or other solid dosage forms | |
US6869618B2 | Process for preparing tannate liquid and semi-solid dosage forms |